Cargando…

A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations

Background: Hospital boards have statutory responsibility for upholding the quality of care in their organisations. International research on quality in hospitals resulted in a research-based guide to help senior hospital leaders develop and implement quality improvement (QI) strategies, the QUASER...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Estela Capelas, Jones, Lorelei, Pomeroy, Linda, Robert, Glenn, Burnett, Susan, Anderson, Janet E., Morris, Steve, Naomi, Fulop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278604/
https://www.ncbi.nlm.nih.gov/pubmed/32610820
http://dx.doi.org/10.34172/ijhpm.2020.91
_version_ 1784746218939744256
author Barbosa, Estela Capelas
Jones, Lorelei
Pomeroy, Linda
Robert, Glenn
Burnett, Susan
Anderson, Janet E.
Morris, Steve
Naomi, Fulop
author_facet Barbosa, Estela Capelas
Jones, Lorelei
Pomeroy, Linda
Robert, Glenn
Burnett, Susan
Anderson, Janet E.
Morris, Steve
Naomi, Fulop
author_sort Barbosa, Estela Capelas
collection PubMed
description Background: Hospital boards have statutory responsibility for upholding the quality of care in their organisations. International research on quality in hospitals resulted in a research-based guide to help senior hospital leaders develop and implement quality improvement (QI) strategies, the QUASER Guide. Previous research has established a link between board practices and quality of care; however, to our knowledge, no board-level intervention has been evaluated in relation to its costs and consequences. The aim of this research was to evaluate these impacts when the QUASER Guide was implemented in an organisational development intervention (iQUASER). Methods: We conducted a ‘before and after’ cost-consequences analysis (CCA), as part of a mixed methods evaluation. The analysis combined qualitative data collected from 66 interviews, 60 hours of board meeting observations and documents from 15 healthcare organisations, of which 6 took part on iQUASER, and included direct and opportunity costs associated with the intervention. The consequences focused on the development of an organisation-wide QI strategy, progress on addressing 8 dimensions of QI (the QUASER challenges), how organisations compared to benchmarks, engagement with the intervention and progress in the implementation of a QI project. Results: We found that participating organisations made greater progress in developing an organisation-wide QI strategy and became more similar to the high-performing benchmark than the comparators. However, progress in addressing all 8 QUASER challenges was only observed in one organisation. Stronger engagement with the intervention was associated with the implementation of a QI project. On average, iQUASER costed £23 496 per participating organisation, of which approximately 44% were staff time costs. Organisations that engaged less with the intervention had lower than average costs (£21 267 per organisation), but also failed to implement an organisation-wide QI project. Conclusion: We found a positive association between level of engagement with the intervention, development of an organisation-wide QI strategy and the implementation of an organisation-wide QI project. Support from the board, particularly the chair and chief executive, for participation in the intervention, is important for organisations to accrue most benefit. A board-level intervention for QI, such as iQUASER, is relatively inexpensive as a proportion of an organisation’s budget.
format Online
Article
Text
id pubmed-9278604
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-92786042022-07-22 A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations Barbosa, Estela Capelas Jones, Lorelei Pomeroy, Linda Robert, Glenn Burnett, Susan Anderson, Janet E. Morris, Steve Naomi, Fulop Int J Health Policy Manag Original Article Background: Hospital boards have statutory responsibility for upholding the quality of care in their organisations. International research on quality in hospitals resulted in a research-based guide to help senior hospital leaders develop and implement quality improvement (QI) strategies, the QUASER Guide. Previous research has established a link between board practices and quality of care; however, to our knowledge, no board-level intervention has been evaluated in relation to its costs and consequences. The aim of this research was to evaluate these impacts when the QUASER Guide was implemented in an organisational development intervention (iQUASER). Methods: We conducted a ‘before and after’ cost-consequences analysis (CCA), as part of a mixed methods evaluation. The analysis combined qualitative data collected from 66 interviews, 60 hours of board meeting observations and documents from 15 healthcare organisations, of which 6 took part on iQUASER, and included direct and opportunity costs associated with the intervention. The consequences focused on the development of an organisation-wide QI strategy, progress on addressing 8 dimensions of QI (the QUASER challenges), how organisations compared to benchmarks, engagement with the intervention and progress in the implementation of a QI project. Results: We found that participating organisations made greater progress in developing an organisation-wide QI strategy and became more similar to the high-performing benchmark than the comparators. However, progress in addressing all 8 QUASER challenges was only observed in one organisation. Stronger engagement with the intervention was associated with the implementation of a QI project. On average, iQUASER costed £23 496 per participating organisation, of which approximately 44% were staff time costs. Organisations that engaged less with the intervention had lower than average costs (£21 267 per organisation), but also failed to implement an organisation-wide QI project. Conclusion: We found a positive association between level of engagement with the intervention, development of an organisation-wide QI strategy and the implementation of an organisation-wide QI project. Support from the board, particularly the chair and chief executive, for participation in the intervention, is important for organisations to accrue most benefit. A board-level intervention for QI, such as iQUASER, is relatively inexpensive as a proportion of an organisation’s budget. Kerman University of Medical Sciences 2020-06-28 /pmc/articles/PMC9278604/ /pubmed/32610820 http://dx.doi.org/10.34172/ijhpm.2020.91 Text en © 2022 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Barbosa, Estela Capelas
Jones, Lorelei
Pomeroy, Linda
Robert, Glenn
Burnett, Susan
Anderson, Janet E.
Morris, Steve
Naomi, Fulop
A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title_full A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title_fullStr A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title_full_unstemmed A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title_short A Board Level Intervention to Develop Organisation-Wide Quality Improvement Strategies: Cost-Consequences Analysis in 15 Healthcare Organisations
title_sort board level intervention to develop organisation-wide quality improvement strategies: cost-consequences analysis in 15 healthcare organisations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278604/
https://www.ncbi.nlm.nih.gov/pubmed/32610820
http://dx.doi.org/10.34172/ijhpm.2020.91
work_keys_str_mv AT barbosaestelacapelas aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT joneslorelei aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT pomeroylinda aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT robertglenn aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT burnettsusan aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT andersonjanete aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT morrissteve aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT naomifulop aboardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT barbosaestelacapelas boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT joneslorelei boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT pomeroylinda boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT robertglenn boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT burnettsusan boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT andersonjanete boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT morrissteve boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations
AT naomifulop boardlevelinterventiontodeveloporganisationwidequalityimprovementstrategiescostconsequencesanalysisin15healthcareorganisations